Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Bridging Nations. Accelerating Therapies for Rare Diseases Together. The organization’s 2030 vision institutionalizes ...

Sidra Medicine, a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six-year-old patient with a rare genetic condition. Marking Rare Disease Day observed ...

The field of cancer genetics and oncogenomics is undergoing a transformative shift as multi-omics approaches become central to understanding the complex ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and ...

In a step that further strengthens Dubai’s global standing in advanced scientific research, a research team at Dubai Health has published a new scientific study in the international medical journal ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

Rare diseases affect more people than cancer yet medicine looked the other way. Artificial intelligence is finally looking back ...

For decades, scientists believed a fertilized egg’s DNA began as a shapeless mass, only organizing itself once the embryo switched on its genes. But new research reveals that the genome is already ...

Since its launch in 2022, the programme has reduced the time to diagnosis from a global average of 7.6 years to just weeks.

Integration of genomic research yields targeted surgical intervention and personalized care program for a young patient ...